ScholarIQanswers from OpenAlex

524 Concurrent Paclitaxel/Cisplatin (PC) with thoracic radiation (TR) in patients with stage IIIab non-small cell lung cancer (NSCLC)

PaperCitations, authors & open-access status

524 Concurrent Paclitaxel/Cisplatin (PC) with thoracic radiation (TR) in patients with stage IIIab non-small cell lung cancer (NSCLC) is a paper indexed in ScholarIQ from OpenAlex.

How many citations does 524 Concurrent Paclitaxel/Cisplatin (PC) with thoracic radiation (TR) in patients with stage IIIab non-small cell lung cancer (NSCLC) have?

ScholarIQcitation count

524 Concurrent Paclitaxel/Cisplatin (PC) with thoracic radiation (TR) in patients with stage IIIab non-small cell lung cancer (NSCLC) has 4 citations in the OpenAlex counts ScholarIQ stores.

When was 524 Concurrent Paclitaxel/Cisplatin (PC) with thoracic radiation (TR) in patients with stage IIIab non-small cell lung cancer (NSCLC) published?

ScholarIQyear

524 Concurrent Paclitaxel/Cisplatin (PC) with thoracic radiation (TR) in patients with stage IIIab non-small cell lung cancer (NSCLC) has 1997 year in the ScholarIQ index.

What is the open-access status of 524 Concurrent Paclitaxel/Cisplatin (PC) with thoracic radiation (TR) in patients with stage IIIab non-small cell lung cancer (NSCLC)?

ScholarIQoa status

524 Concurrent Paclitaxel/Cisplatin (PC) with thoracic radiation (TR) in patients with stage IIIab non-small cell lung cancer (NSCLC) has closed oa status in the ScholarIQ index.

What is the DOI of 524 Concurrent Paclitaxel/Cisplatin (PC) with thoracic radiation (TR) in patients with stage IIIab non-small cell lung cancer (NSCLC)?

ScholarIQdoi

The DOI for 524 Concurrent Paclitaxel/Cisplatin (PC) with thoracic radiation (TR) in patients with stage IIIab non-small cell lung cancer (NSCLC) is on the source record.

What is the OpenAlex record for 524 Concurrent Paclitaxel/Cisplatin (PC) with thoracic radiation (TR) in patients with stage IIIab non-small cell lung cancer (NSCLC)?

ScholarIQopenalex

The OpenAlex for 524 Concurrent Paclitaxel/Cisplatin (PC) with thoracic radiation (TR) in patients with stage IIIab non-small cell lung cancer (NSCLC) is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial